Quest Diagnostics's most recent trend suggests a bullish bias. One trading opportunity on Quest Diagnostics is a Bull Put Spread using a strike $60.00 short put and a strike $50.00 long put offers a potential -0.5% return on risk over the next 8 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $60.00 by expiration. The full premium credit of $-0.05 would be kept by the premium seller. The risk of $10.05 would be incurred if the stock dropped below the $50.00 long put strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for Quest Diagnostics is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Quest Diagnostics is bullish.
The RSI indicator is below 20 which suggests that the stock is in oversold territory.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Quest Diagnostics
CollabRx Teams With Quest Diagnostics in Clinical Genetic Sequencing
Mon, 11 Nov 2013 12:01:00 GMT
GlobeNewswire – SAN FRANCISCO — CollabRx, Inc. , a data analytics company focused on informing clinical decision making in molecular medicine, today announced a multi-year, non-exclusive agreement with Quest Diagnostics …
Quest Diagnostics to Speak at the Credit Suisse 2013 Annual Healthcare Conference
Mon, 11 Nov 2013 03:25:57 GMT
noodls – MADISON, N.J., Nov. 8, 2013 /PRNewswire/ — Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Credit …
Quest Diagnostics to Speak at the Credit Suisse 2013 Annual Healthcare Conference
Fri, 08 Nov 2013 22:25:00 GMT
PR Newswire – MADISON, N.J., Nov. 8, 2013 /PRNewswire/ — Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Credit …
Quest Diagnostics Inc. (DGX) is Overbought, What's Next?
Fri, 08 Nov 2013 11:04:32 GMT
Quest Diagnostics initiated with a Market Perform at FBR Capital
Fri, 08 Nov 2013 10:49:11 GMT
Related Posts
Also on Market Tamer…
Follow Us on Facebook